PEDF inhibits VEGF- and EPO- induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation (Q43297982)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

18 November 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

PEDF inhibits VEGF- and EPO- induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation (English)

1 reference

18 November 2017

0 references

1 reference

Banumathi Elayappan

1

1 reference

18 November 2017

Haribalaganesh Ravinarayannan

2

1 reference

18 November 2017

Sheik Pran Babu Sardar Pasha

3

1 reference

18 November 2017

Kyung-jin Lee

4

1 reference

18 November 2017

Sangiliyandi Gurunathan

5

1 reference

18 November 2017

language of work or name

1 reference

1 January 2009

1 reference

18 November 2017

1 reference

18 November 2017

12

1 reference

18 November 2017

4

1 reference

18 November 2017

313-324

1 reference

https://scigraph.springernature.com/pub.10.1007/s10456-009-9153-5

18 November 2017

0 references

cites work

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

PEDF: a potential molecular therapeutic target with multiple anti-cancer activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Erythropoietin receptor mRNA expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

How PEDF prevents angiogenesis: a hypothesized pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Signalling through the lipid products of phosphoinositide-3-OH kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

High-yielding enzymatic method for isolation and culture of microvascular endothelial cells from bovine retinal blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Interleukin 3-dependent survival by the Akt protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Chronically elevated glucose-induced apoptosis is mediated by inactivation of Akt in cultured Müller cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Octreotide prevents growth factor-induced proliferation of bovine retinal endothelial cells under hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

PI3K: downstream AKTion blocks apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-009-9153-5

Akt takes center stage in angiogenesis signaling

21 January 2018

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S10456-009-9153-5

Recombinant human erythropoietin stimulates angiogenesis in vitro

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S10456-009-9153-5

Tipping the balance for angiogenic disorders

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1007/S10456-009-9153-5

Identifiers

DOI

10.1007/S10456-009-9153-5

1 reference

Dimensions Publication ID

18 November 2017

0 references

1 reference